Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial

Lars Gullestad; Martin Iversen; Svend-Aage Mortensen; Hans Eiskjaer; Gerdt C Riise; Lena Mared; Oystein Bjørtuft; Björn Ekmehag; Kjell Jansson; Svein Simonsen; Einar Gude; Bengt Rundqvist; Hans E Fagertun; Dag Solbu; Claes-Håkan Bergh

doi:10.1097/TP.0b013e3181cbac2d

Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial

Lars Gullestad, Martin Iversen, Svend-Aage Mortensen, Hans Eiskjaer, Gerdt C Riise, Lena Mared, Oystein Bjørtuft, Björn Ekmehag, Kjell Jansson, Svein Simonsen, Einar Gude, Bengt Rundqvist, Hans E Fagertun, Dag Solbu, Claes-Håkan Bergh

130 Citations (Scopus)

Abstract

The proliferation signal inhibitor everolimus offers the potential to reduce calcineurin inhibitor (CNI) exposure and alleviate CNI-related nephrotoxicity. Randomized trials in maintenance thoracic transplant patients are lacking.

Original language	English
Journal	Transplantation
Volume	89
Issue number	7
Pages (from-to)	864-72
Number of pages	9
ISSN	0041-1337
DOIs	https://doi.org/10.1097/TP.0b013e3181cbac2d
Publication status	Published - 15 Apr 2010

Access to Document

10.1097/TP.0b013e3181cbac2d

Cite this

Gullestad, L., Iversen, M., Mortensen, S.-A., Eiskjaer, H., Riise, G. C., Mared, L., Bjørtuft, O., Ekmehag, B., Jansson, K., Simonsen, S., Gude, E., Rundqvist, B., Fagertun, H. E., Solbu, D., & Bergh, C.-H. (2010). Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial. Transplantation, 89(7), 864-72. https://doi.org/10.1097/TP.0b013e3181cbac2d

Gullestad, L, Iversen, M, Mortensen, S-A, Eiskjaer, H, Riise, GC, Mared, L, Bjørtuft, O, Ekmehag, B, Jansson, K, Simonsen, S, Gude, E, Rundqvist, B, Fagertun, HE, Solbu, D & Bergh, C-H 2010, 'Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial', Transplantation, vol. 89, no. 7, pp. 864-72. https://doi.org/10.1097/TP.0b013e3181cbac2d

@article{8fcc2363b1a84ff39cfd5b319582adbf,

title = "Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial",

abstract = "The proliferation signal inhibitor everolimus offers the potential to reduce calcineurin inhibitor (CNI) exposure and alleviate CNI-related nephrotoxicity. Randomized trials in maintenance thoracic transplant patients are lacking.",

author = "Lars Gullestad and Martin Iversen and Svend-Aage Mortensen and Hans Eiskjaer and Riise, \{Gerdt C\} and Lena Mared and Oystein Bj{\o}rtuft and Bj{\"o}rn Ekmehag and Kjell Jansson and Svein Simonsen and Einar Gude and Bengt Rundqvist and Fagertun, \{Hans E\} and Dag Solbu and Claes-H{\aa}kan Bergh",

year = "2010",

month = apr,

day = "15",

doi = "10.1097/TP.0b013e3181cbac2d",

language = "English",

volume = "89",

pages = "864--72",

journal = "Transplantation",

issn = "0041-1337",

publisher = "Lippincott Williams and Wilkins",

number = "7",

}

TY - JOUR

T1 - Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial

AU - Gullestad, Lars

AU - Iversen, Martin

AU - Mortensen, Svend-Aage

AU - Eiskjaer, Hans

AU - Riise, Gerdt C

AU - Mared, Lena

AU - Bjørtuft, Oystein

AU - Ekmehag, Björn

AU - Jansson, Kjell

AU - Simonsen, Svein

AU - Gude, Einar

AU - Rundqvist, Bengt

AU - Fagertun, Hans E

AU - Solbu, Dag

AU - Bergh, Claes-Håkan

PY - 2010/4/15

Y1 - 2010/4/15

N2 - The proliferation signal inhibitor everolimus offers the potential to reduce calcineurin inhibitor (CNI) exposure and alleviate CNI-related nephrotoxicity. Randomized trials in maintenance thoracic transplant patients are lacking.

AB - The proliferation signal inhibitor everolimus offers the potential to reduce calcineurin inhibitor (CNI) exposure and alleviate CNI-related nephrotoxicity. Randomized trials in maintenance thoracic transplant patients are lacking.

UR - https://www.scopus.com/pages/publications/77950952997

U2 - 10.1097/TP.0b013e3181cbac2d

DO - 10.1097/TP.0b013e3181cbac2d

M3 - Journal article

C2 - 20061999

SN - 0041-1337

VL - 89

SP - 864

EP - 872

JO - Transplantation

JF - Transplantation

IS - 7

ER -

Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial

Abstract

Access to Document

Other files and links

Fingerprint

Cite this